1. Long‐term follow‐up of dose‐adjusted EPOCH plus rituximab (DA‐EPOCH‐R) in untreated patients with poor prognosis large B‐cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group. (18th December 2014) Authors: Purroy, Noelia; Bergua, Juan; Gallur, Laura; Prieto, Julio; Lopez, Luis A.; Sancho, Juan M.; García‐Marco, Jose A.; Castellví, Josep; Montes‐Moreno, Santiago; Batlle, Ana; de Villambrosia, Sonia Gonzalez; Carnicero, Fernando; Ferrando‐Lamana, Lucía; Piris, Miguel A; Lopez, Andrés Journal: British journal of haematology Issue: Volume 169:Number 2(2015:Apr.) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗